BAN-Dep: A Trial to Decrease the Prevalence of Depression in Australian Nursing Homes.

Not Applicable

• Conditions: Depression; Mental Health - Depression

• Registration Number: ACTRN12618000634279
• Lead Sponsor: The University of Western Australia - School of Medicine/Division of Psychiatry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-23
• Study Completion: 2021-12-17
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 193

Inclusion Criteria

RACF:
Consent to be granted by RACF,
RACF manager to appoint MHC for their facility.
MHC must be able to communicate effectively in English.

Residents:
- 60 years or over
- Permanent residents of aged care facilities
- Screens positive on at least one of two questions known as the Whooley depression screening questions: low mood or decreased interest / enjoyment in usual activities.

Aged care facility staff:
Must be able to communicate effectively in English

Exclusion Criteria

- Mini-Mental State Examination (MMSE) score lower than 18 (moderate to severe cognitive impairment (those with dementia and MMSE equal to 18 and above will be eligible to participate),
- A disorder that impedes effective communication (e.g., severe sensory impairment),
- Active psychotic symptoms or suicidal ideation,
- PHQ-9 score less than 5 (i.e., no or minimal depressive symptoms),
- Difficulty communicating effectively in English,
- Failed (or are unable) to provide informed consent to participate.

MHC and aged care facility staff:
- Difficulty communicating effectively in English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire (PHQ-9) <br><br>A multipurpose instrument used for screening, diagnosing, monitoring and measuring the severity of depression. The PHQ-9 questionnaire incorporates DSM-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self report tool.[Outcome measures will be collected at baseline, 12, (primary time point) 26 and 52 weeks. All time points will be included in the analysis.<br>]